USA

CBD pet products may face more FDA warnings, lawsuits

Photo: R+R Medicinals, Pixabay
Photo: R+R Medicinals, Pixabay
15.10.2020

The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol (CBD). That draft is currently at the White House for review.
"Pet product companies that formulate with CBD, or are considering it, should mind the outcome of that policy", Emily Lyons, lawyer with Husch Blackwell, said during her presentation at Petfood Forum Connect. "I would expect that this enforcement policy would look very similar to what FDA has included in warning letters to companies."
FDA officials may consider CBD-containing pet products to be adulterated, because the agency ruled that CBD as an ingredient or additive is not generally recognised as safe (GRAS) in animal feed. The agency could also view the products as unapproved new animal drugs, which includes reference to disease treatment claims.
Back to homepage
Related articles
The new subscription:
Deep insights, facts & figures
2 issues free trial
petworldwide
Read also